Editas Medicine editasmedicine.com


Public list: BIO 2016 (619) Smart Money VCs (6327) Synthetic Biology (132)

Editas Medicine is a genome editing company and part of a transformational new area of health care – genomic medicine. The company was founded by pioneers and world leaders in genome editing bringing specific expertise in CRISPR/Cas9 and TALENs technologies. The company's mission is to translate its proprietary technology into novel solutions to treat a broad range of genetically driven diseases.

Editas Medicine is a genome editing company and part of a transformational new area of health care – genomic medicine. The company was founded by pioneers and world leaders in genome editing bringing specific expertise in CRISPR/Cas9 and TALENs tec...Show all

Company (IPO / Went public)

All investors data 17 Investors

Phone: 617-401-9000

Fax:

300 Third Street
First Floor
 Cambridge, 02142
 Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Editas Medicine $282.4M Feb 3, 2016
CRISPR Therapeutics $218M Oct 19, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Editas Medicine Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 17 investors

Board Members

Name Firm
Login to see detailsPolaris Partners
Login to see detailsThird Rock Ventures
Login to see detailsFlagship Pioneering
Login to see detailsPolaris Partners
Login to see detailsBiomatics Capital Partners

Competitors

Company Status Description Investors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Crispr/cas-related methods and compositions for treating cystic fibrosis Oct 07, 2016 Application
Crispr/cas-related methods and compositions for treating herpes simplex virus type 1 (hsv-1) Sep 30, 2016 Application
Crispr/cas-related methods and compositions for treating hiv infection and aids Sep 23, 2016 Application
Crispr/cas-mediated gene conversion Mar 25, 2016 Application
Crispr/cas-related methods and compositions for treating primary open angle glaucoma Apr 01, 2015 Application
See all 8 patents